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Background—In Denmark, primary percutaneous coronary intervention (PPCI) was chosen as a national reperfusion
strategy for patients with ST-segment elevation myocardial infarction in 2003. This study describes the temporal
implementation of PPCI in Western Denmark, the gradual introduction of field triage for PPCI (patients rerouted from
the scene of the event directly to the invasive center), and the associated outcome.
Methods and Results—The study population comprised 9514 patients treated with PPCI from 1999 to 2009 with symptom
duration12 hours and either a delay from the emergency medical service (EMS) call to PPCI (healthcare system delay)
of 6 hours or as self-presenters. The median follow-up time was 3.7 years. The number of patients treated with PPCI
increased from 190 in 1999 to 1212 in 2009. Among patients transported by the EMS from the scene of the event, the
proportion who were field triaged directly to a PCI center increased from 33% (34/103) to 72% (616/851, P0.001).
Patients who were field triaged had lower long-term mortality, with adjusted hazard ratios (95% CI) of 1.26 (1.12–1.43)
among patients transported by the EMS to a local hospital and then transferred, 1.28 (1.10–1.49) among patients
self-presenting at a local hospital and then transferred, and 1.37 (1.18–1.58) among patients self-presenting at a PCI
center.
Conclusions—A reperfusion strategy with PPCI only for patients with ST-segment elevation myocardial infarction was
successfully implemented in Western Denmark, and the majority of patients transported by the EMS are now triaged directly
to the PPCI centers. This strategy is associated with lower mortality. (Circ Cardiovasc Interv. 2011;4:570-576.)
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In 2003, primary percutaneous coronary intervention(PPCI) was chosen as a national reperfusion strategy for
patients with ST-segment elevation myocardial infarction
(STEMI) in Denmark.1 To facilitate triage of patients directly
to the PPCI centers, a prehospital diagnostic program was
launched. The purpose of the present study was to describe
the gradual implementation of PPCI from 1999 until 2009,
the temporal change in triage of patients directly to PPCI
centers, and the associated clinical outcome.
Methods
Geographical Area
The study was conducted in Western Denmark, which has a
population of 3 034 740, corresponding to 55% of the Danish
population. The region has 3 PPCI centers located in the 3 largest
cities (Aalborg, Aarhus, and Odense). The cities have populations of
123 432, 242 914, and 166 305, respectively, and the total catchment
areas of the 3 PPCI centers are 580 515, 1 253 998, and 1 200 227,
respectively, when including rural areas. The region has 22 somatic
hospitals without PPCI facilities. All PPCI centers offer 24-hours/
day, 7-days/week services. The distance from north to south is 400
km and from east to west, 190 km. The longest transport distance to
a PPCI center is 180 km. One major emergency medical service
(EMS) provider (Falck A/S; Copenhagen, Denmark) covers 90%
of all EMS calls in Western Denmark.
Design
This historical follow-up study was based on public medical data-
bases covering the entire population of Western Denmark. The
Danish National Health Service provides tax-supported free health
care for all inhabitants, guaranteeing free access to EMS services,
treatment by general practitioners, and free hospital treatment.
Unambiguous, individual-level linkage between the databases used
in this study was possible through the civil registration number,
which is a unique, 10-digit personal identification number assigned
to every Danish citizen at birth.2,3
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WHAT IS KNOWN
● Primary percutaneous coronary intervention (PPCI)
is recommended as the preferred reperfusion strategy
in patients with ST-segment elevation myocardial
infarction if initiated in a timely manner.
WHAT THE STUDY ADDS
● Successful implementation of PPCI is the only rep-
erfusion strategy used in Denmark.
● When combining prehospital diagnosis with field
triage, the majority of patients with ST-segment
elevation myocardial infarction are admitted directly
to the invasive center for PPCI.
Patients and Procedures
The study population consisted of patients with STEMI or presumed
bundle branch block myocardial infarction admitted for PPCI in
Western Denmark between January 1, 1999, and December 31, 2009.
Patients were identified in the Western Denmark Heart Registry,
which collects baseline characteristics and patient- and procedure-
specific information on all angiographies and coronary interventions
performed in the region. In Denmark, PPCI for STEMI was chosen
as the preferred reperfusion strategy after publication of the Danish
Trial of Acute Myocardial Infarction-2 (DANAMI-2) in 2003.1
Patients must meet the following criteria to be eligible for PPCI:
symptom duration of12 hours and ST-segment elevation0.1 mV
in at least 2 contiguous leads (0.2 mV in V1–V3) or presumed
new-onset left bundle branch block. In 1999, prehospital diagnosis
using telemedicine was introduced,4 and in 2000, the National Board
of Health decided that before 2006, all EMS vehicles should have
equipment for 12-lead ECG acquisition and wireless transmission to
a physician at the hospital. Field triage of patients directly to PPCI
centers was introduced in 2003.5–8 Ambulance physicians were
gradually introduced in the larger cities within the study area. During
the study period, 18 410 patients with suspected STEMI or bundle
branch block myocardial infarction were transferred from other
hospitals or admitted directly to 1 of the 3 PPCI centers. The first
index contact during the study period (n17 513) was included in
the analyses, of which 12 403 patients underwent PPCI. Mortality
data were not available in 216 patients, who were foreign citizens or
had emigrated. Patients with a treatment delay of 12 hours
(n2154) or with missing treatment delay data (n189), patients
transported with the EMS and with a system delay of 6 hours
(n292), and patients with missing system delay data (n38) were
excluded. Thus, the study cohort comprised 9514 patients.
Time Delays
The estimation of various delays to initiation of reperfusion therapy
was based on prehospital data registered by the EMS provider (Falck
A/S) and time of symptom onset and first catheterization with a
guiding catheter during PPCI registered in the Western Denmark
Heart Registry. Treatment delay was calculated as the time from
symptom onset to first catheterization with a guiding catheter during
PPCI, patient delay as the time from symptom onset to EMS call,
system delay as the time from EMS call to first catheterization with
a guiding catheter during PPCI, and door-to-balloon delay as the
time from arrival at the PPCI center to the first catheterization with
a guiding catheter during PPCI (Figure 1).
Mortality
Data on mortality was obtained from the Danish Civil Registration
System, which has kept electronic records on the sex, date of birth,
change of address, date of emigration, and changes in vital status of
the entire Danish population since 1968.9
Covariates
Baseline characteristics and other covariates (Table 1) were derived
from the Danish Civil Registration System and the Western Denmark
Heart Registry.
Statistical Analysis
Dichotomous data are presented as percentages. Continuous vari-
ables are presented as median (interquartile range). The Fisher exact
test, 2 test, Mann-Whitney test, and Kruskal-Wallis test were used
for comparisons of categorical and continuous variables as appro-
priate. Significance was set at P0.05 (2-sided test). Follow-up
began on the date of PPCI and ended on the date of death;
emigration; June 25, 2010; or after 7 years of follow-up (to ensure at
least 10% of the study population at risk), whichever came first.
Kaplan-Meier curves were constructed and stratified according to
availability of EMS data and mode of prehospital triage. Compari-
sons between groups were made using log-rank statistics. Cox
proportional hazards regression analysis was used to examine the
association between possible predictors of outcome (see Table 1 for
complete list) and time to death. Hazard ratios (HRs) with 95% CIs
are presented. The proportional hazard assumption was checked for
each categorical variable through visual inspection and by the
method described by Grambsch and Therneau10 using the scaled
Schoenfeld residuals. For continuous variables, the linearity assump-
tion was checked graphically using the Martingale residuals. Cox-
Snell residuals were used to assess the overall model fit. Systolic and
diastolic blood pressure levels were converted to categorical values
(110, 110–129, 130–144, and 145 mm Hg) because they did not
fulfill the linearity assumption. Crude and mutually adjusted HRs
with 95% CIs were computed. Variables associated with time to
death in the univariable Cox regression analyses (Wald test P0.05)
were included in multivariable Cox regression models. In the
multivariable models, missing values were replaced with their
conditional means. These values were obtained as predictions from a
regression model using all nonmissing covariates for each sub-
ject.11,12 The same method for assigning missing values was used for
categorical variables without rounding the binary outcome, as
previously proposed by Allison13 when proportions are not close to
0 or 1. All statistical analyses were performed using STATA 11.0
(StataCorp LP; College Station, TX).
Results
The study cohort comprised 9514 patients with STEMI.
Prehospital data from the EMS provider were available in
7858 (83%) patients, whereas 1656 (17%) had no EMS data
and were presumed to be self-presenters at the PPCI centers.
The number of patients included in the study cohort increased
from 190 in 1999 to 1212 patients in 2009 (Figure 2). Among
patients transported by the EMS from the scene of the event,
the proportion triaged directly to a PPCI center increased
from 33% (34/103) in 1999 to 72% (616/851) in 2009
(P0.001). When stratifying according to whether EMS data
were available and whether patients transported by the EMS
were transferred from local hospitals or field triaged directly
to the PPCI center, there were significant differences in
several baseline characteristics (Table 1). In patients triaged
directly to a PPCI center (n3053) the median (interquartile
range) system delay was 99 (80–127) minutes; in patients
transported by the EMS to the local hospital and transferred
to a PPCI center (n3291), it was 159 (130–199) minutes;
and in patients self-presenting at a local hospital and trans-
ferred (n1514), it was 92 (72–119) minutes. The corre-
sponding door-to-balloon delays were 39 (24–69), 33 (23–
92), and 26 (20–69) minutes, respectively (Table 1). For the
same groups, the proportion of patients treated with a system
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delay of 120 minutes was 70% (n2136), 17% (n572),
and 76% (n1146), respectively, and the proportion of
patients treated with a door-to-balloon delay of 90 minutes
was 86% (n2017), 74% (n1941), and 94% (n911),
respectively. The median follow-up time was 3.7 years
(interquartile range, 1.7–5.9 years), with a 1-year absolute
mortality of 9.8% (n937) and long-term absolute mortality
(median follow-up, 3.7 years) of 18.5% (n1764). For
patients triaged directly to the PPCI center, transported by the
EMS to a local hospital and transferred, self-presenting at a
Figure 1. Various delays to reperfusion with PPCI
in patients with ST-segment elevation myocardial
infarction. PCI, percutaneous coronary intervention;
PPCI, primary PCI.
Table 1. Characteristics of Patients With STEMI Treated With PPCI, Stratified According to Prehospital Triage (n9514)
Characteristics
EMS Transport to a PCI
Center (Field Triage)
(n3053)
Self-Presenting at a PCI
Center (n1656)
EMS Transport to a
Local Hospital and
Transfer (n3291)
Self-Presenting at a
Local Hospital and
Transfer (n1514)
PValue
Valid
Cases Value
Valid
Cases Value
Valid
Cases Value
Valid
Cases
Demographics
Age, y 64 (56–74) 3053 63 (54–73) 1656 65 (57–75) 3291 63 (53–73) 1514 0.001
Female sex 790 (26) 3053 433 (26) 1656 894 (27) 3291 401 (26) 1514 0.69
Comorbidities
Treatment for hypertension 866 (32) 2730 478 (32) 1486 912 (31) 2950 418 (30) 1376 0.68
Diabetes 306 (11) 2821 204 (13) 1549 353 (12) 3057 162 (11) 1433 0.14
Previous myocardial infarction 271 (10) 2712 201 (14) 1481 362 (12) 2932 163 (12) 1365 0.003
Previous PCI 194 (7.2) 2706 129 (8.7) 1484 193 (6.7) 2920 92 (6.8) 1363 0.075
Previous congestive heart failure 79 (2.6) 3053 64 (3.9) 1656 125 (3.8) 3291 51 (3.4) 1514 0.031
Active or previous smoker 2025 (77) 2620 1045 (76) 1374 2157 (77) 2806 1049 (78) 1337 0.50
Delays and transportation
Treatment delay, min 175 (120–265) 3053 180 (118–277) 1656 235 (171–327) 3291 248 (175–373) 1514 0.001
Patient delay, min 76 (33–162) 2728 NA 80 (36–171) 2763 155 (87–276) 1457 0.001
System delay, min 99 (80–127) 3053 NA 159 (130–199) 3291 92 (72–119) 1514 0.001
Door-to-balloon delay, min 39 (24–69) 2333 NA 33 (23–92) 2620 26 (20–39) 1055 0.001
Transportation, km 26 (7–50) 3053 NA 77 (48–111) 3291 54 (37–97) 1514 0.001
Clinical characteristics
Body mass index, kg/m2 26 (24–29) 1726 26 (24–29) 676 26 (24–29) 1568 26 (20–39) 1055 0.81
Systolic blood pressure, mm Hg 130 (112–145) 2373 130 (111–145) 1229 125 (110–140) 2253 128 (110–141) 1071 0.001
Diastolic blood pressure, mm Hg 75 (65–85) 2364 75 (65–83) 1220 75 (64–80) 2243 75 (65–81) 1065 0.001
Killip class 2936 1586 3187 1440
I 2657 (91) 1404 (89) 2888 (91) 1294 (90)
II 156 (5.3) 88 (5.6) 149 (4.7) 70 (4.9) 0.11
III 56 (1.9) 41 (2.6) 73 (2.3) 44 (3.1)
IV 67 (2.3) 53 (3.3) 77 (2.4) 32 (2.2)
Anterior STEMI or BBBMI 1222 (45) 2748 593 (41) 1445 1266 (44) 2884 588 (45) 1314 0.14
Culprit vessel 2959 1605 3206 1466
Left main 49 (1.7) 32 (2.0) 51 (1.6) 21 (1.4)
Left anterior descending artery 1293 (44) 658 (41) 1377 (43) 672 (46) 0.39
Circumflex artery 413 (14) 219 (14) 449 (14) 194 (13)
Right coronary artery 1204 (41) 696 (43) 1329 (41) 579 (40)
Multivessel disease 1265 2961 711 (46%) 1561 1498 (47) 3183 652 (45) 1435 0.008
Data are presented as median (interquartile range) or n (%). BBBMI indicates bundle branch block myocardial infarction; door-to-balloon delay, time from arrival
at PPCI center to PPCI; EMS, emergency medical service; patient delay, time from symptom onset to EMS; PPCI, primary percutaneous coronary intervention; STEMI,
ST-segment elevation myocardial infarction; system delay, time from EMS call to PPCI; treatment delay, time from symptom onset to PPCI.
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local hospital and transferred, and self-presenting at a PPCI
center, 1-year cumulative mortality was 8.1% (n234),10.7%
(n346), 10.6 (n156), and 12.5% (n201), respectively
(log-rank P0.001), and long-term cumulative mortality was
21.3% (n424), 27.1% (n702), 26.9% (n309), and 26.9%
(n328), respectively (log-rank P0.001) (Figure 3). After
adjustment for other risk factors, including treatment delay,
field-triaged patients had the lowest long-term mortality, with
adjusted HRs (95% CI) of 1.26 (1.12–1.43) in patients trans-
ported by the EMS to a local hospital and transferred to a PPCI
center, 1.28 (1.10–1.49) in patients self-presenting at a local
hospital and transferred to a PPCI center, and 1.37 (1.18–1.58)
in patients self-presenting at a PPCI center (Figure 4, Table 2).
When restricting analyses to patients with available EMS data
and adjusting for system delay, field-triaged patients still had
lower mortality compared with patients transferred from other
hospitals (Table 2).
Discussion
The main findings in the present study is that prehospital
diagnosis and triage of patients with STEMI can be success-
fully implemented at a national level to ensure that the
majority of patients are triaged directly to a PPCI center with
an associated lower mortality. In 2003, Denmark was the first
country to implement PPCI as a national reperfusion strategy.
This decision was based on the DANAMI-2 trial, which
documented that PPCI was superior to fibrinolysis when
looking at a combined end point of death, reinfarction, and
stroke.1 This strategy is supported by American and European
guidelines that recommend PPCI as the preferred reperfusion
strategy when performed in a timely manner.14–17 It is also
supported by a meta-analysis from Boersma and colleagues 18
based on randomized controlled trials comparing fibrinolysis
with PPCI, documenting a significant reduction in mortality
achieved by PPCI compared with fibrinolysis. However, in
the Boersma et al meta-analysis, a mortality benefit was
achieved by PPCI despite that prehospital diagnosis and field
triage of patients was not performed in the large majority of
the trials implemented. Thus, a substantial delay was seen at
the local hospitals before transfer of patients. In the
DANAMI-2 trial, this delay was 50 minutes,1 and no diag-
noses were made for patients in the prehospital phase. From
1999, when the DANAMI-2 trial was still ongoing, prehos-
pital diagnosis was gradually introduced in Denmark.4 From
2006, all EMS vehicles had equipment for ECG transmission,
and when combining prehospital diagnosis with field triage
directly to PPCI centers, a1-hour reduction in overall delay
from the EMS call to PPCI (system delay) was observed.6,19
Accordingly, triage of patients with STEMI for PPCI has
improved considerably after the DANAMI-2 trial and the
Figure 2. Patients with ST-segment elevation
myocardial infarction treated with PPCI during
and after DANAMI-2 (Danish Trial of Acute
Myocardial Infarction-2), stratified according to
prehospital triage and whether patients were
transported by EMS. EMS indicates emergency
medical service. Other abbreviations as in
Figure 1.
Figure 3. Kaplan-Meier cumulative mortality esti-
mates for patients with ST-segment elevation myo-
cardial infarction treated with PPCI (n9514),
stratified according to prehospital triage and
whether EMS data were available. Abbreviations
as in Figures 1 and 2.
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other trials included in the Boersma et al meta-analysis. We
have previously documented that each 1-hour increase in
system delay is associated with a 10% relative increase in
mortality.20 With a 1-year mortality of 10% to 11%, this
means that the number of patients saved by a 1-hour earlier
reperfusion therapy is estimated to be 10 per 1000 treated.
The HR of 1.26 (95% CI, 1.12–1.43) observed in the present
study among patients transported by the EMS to a local
hospital and then transferred could indicate that the benefit of
triaging patients directly to PPCI centers may not only be
explained by a reduction in system delay. There is, of course,
the risk of selection bias and residual confounding, but
another possibility is that prompt admission to tertiary centers
provides benefit in addition to the mortality reduction
achieved by earlier PPCI. The observed HR of 1.084 per
1-hour increase in system delay (Table 2, model 2) does not
contradict this because system delay and mode of triage are
highly correlated, and when implementing both parameters in
the analysis, there is a risk of overadjustment (ie, the risk that
we underestimate the impact of both covariates on outcome).
The present study documents that a widespread implementa-
tion of a prehospital diagnostic program is possible with the use
of telemedicine and ambulance physicians, enabling field triage
directly to PPCI centers in the majority of patients with STEMI.
However, there is still room for improvement. Thus, at the end
of the study period, 30% of patients transported by the EMS
from the scene of the event were still driven to the local hospital
and then transferred for PPCI. The overall aim is to field triage
90% of patients with STEMI, which is achievable in regions
with a special focus on prehospital diagnosis.19 Whereas previ-
ous studies have mainly addressed regional initiatives for im-
proving triage of patients, the present study is considered to
reflect the current use of prehospital diagnosis and field triage of
patients at a national level because (1) it represents the majority
of the Danish people; (2) the prehospital diagnostic strategy was
implemented at a national level; (3) the same strategy of
implementing telemedicine in all ambulance vehicles and im-
plementing ambulance physicians in larger cities was prioritized
throughout Denmark; and (4) in eastern Denmark, treatment
with PPCI has been centralized at large PPCI centers (Copen-
hagen and Gentofte) that run 24 hours/day, 7 days/week. It is
clear that field triage directly to PPCI centers is mandatory to
ensure that the majority of patients with STEMI are treated
within 2 hours of an EMS call, as recommended by the
American and European guidelines,14–17 and further efforts
should be put into ensuring that the remaining patients trans-
ported by the EMS from the scene of the event also are triaged
directly to a PPCI center. Although there are numerous data on
the use of PPCI in different countries, there is limited informa-
tion regarding actual triage of patients with STEMI, which is of
importance for outcome.21 We should consider implementing
prehospital triage of patients with STEMI directly to PCI centers
as a general quality-of-care measure.
Limitations
After PPCI was fully implemented as the preferred reperfu-
sion therapy in 2004, patients with STEMI were routinely
admitted or transferred for PCI. Fibrinolysis may have been
used in a small number of patients, but unfortunately, there
are no registries recording the use of fibrinolysis. Among
patients transferred from a local hospital to a PPCI center,
there were no data on EMS transportation to the local hospital
in 32% of cases. These patients were assumed to be self-pres-
enters at the local hospital. However, from previous studies,
we know that16% are self-presenters at the local hospital,22
and thus, the group of patients classified as self-presenters at
the local hospital is a mixed group that also comprises some
patients with missing EMS data for the transport to the local
hospital. Likewise, the number of patients classified as
self-presenting at a PPCI center is larger than expected, and
herein, a group of patients with missing EMS data for
transportation to the PPCI center has been classified as
Figure 4. Hazard ratios for the association
between various covariates and mortality dur-
ing follow-up as derived from model 1 in Table
2 (n9514). BBBMI indicates bundle branch
block myocardial infarction; STEMI,
ST-segment elevation myocardial infarction.
Other abbreviations as in Figures 1 and 2.
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self-presenters. There is no reason to believe that this has any
impact on the main conclusions because it results in an
underestimation of the proportion of patients transported by
the EMS and underestimates the association between the
mode of triage or system delay and mortality. There is no
registry on patients with STEMI who are not receiving
reperfusion therapy and no data on deaths before PCI.
Regarding timing of reperfusion in PPCI, time of first balloon
inflation normally is used as the time of reperfusion. How-
ever, reperfusion often is achieved already during wiring or
thrombectomy. Because data on first wiring or thrombectomy
were available in only a minority of patients and because
insertion of the guiding catheter is followed within a few
minutes by the first coronary intervention, we routinely use
time of guiding catheter insertion as the time of first inter-
vention. Further, because the phrase door to balloon is a
widely accepted term, we decided to use this term synony-
mously with time from arrival at the PPCI center to first
guiding catheter insertion.
Conclusions
A reperfusion strategy with PPCI only for STEMI was
successfully implemented in Western Denmark, and a pre-
hospital diagnostic program has ensured that the majority of
patients transported by the EMS are triaged directly to PPCI
centers, which is associated with lower mortality.
Table 2. Multivariable Cox Regression Analysis of Covariates Associated With Long-Term Mortality in Patients With
STEMI or BBBMI Treated With PPCI
Covariates
Model 1, All Patients (n9514)*
Model 2, Patients With EMS Data
(n7858)*
HR (95% CI) P HR (95% CI) P
Demographics
Age, per 10-y increase 1.92 (1.83–2.01) 0.001 1.96 (1.86–2.07) 0.001
Female sex 1.004 (0.90–1.12) 0.94 1.004 (0.89–1.13) 0.94
Comorbid conditions
Treatment for hypertension 1.009 (0.91–1.12) 0.87 1.06 (0.94–1.20) 0.31
Diabetes 1.99 (1.75–2.26) 0.001 1.90 (1.64–2.19) 0.001
Previous myocardial infarction 1.18 (1.03–1.36) 0.016 1.10 (0.94–1.29) 0.24
Previous congestive heart failure 1.70 (1.43–2.03) 0.001 1.64 (1.35–2.00) 0.001
Active or previous smoker 1.13 (1.003–1.27) 0.045 1.14 (1.001–1.30) 0.049
Triage of patients
EMS transport to a PCI center (field triage) 1 (reference) 1 (reference)
Self-presenting at a PCI center 1.37 (1.18–1.58) 0.001 NA
EMS transport to a local hospital and transfer 1.26 (1.12–1.43) 0.001 1.14 (0.997–1.31) 0.056
Self-presenting at a local hospital and transfer 1.28 (1.10–1.49) 0.001 1.28 (1.10–1.49) 0.001
Delays, per 1-h increase
Treatment delay 0.994 (0.98–1.013) 0.54 . . .
Patient delay . . . 1.004 (0.98–1.029) 0.76
System delay . . . 1.084 (1.021–1.15) 0.008
Clinical characteristics
Body mass index, per 1-unit increase 0.97 (0.95–0.99) 0.002 0.97 (0.95–0.99) 0.007
Systolic blood pressure, mm Hg
110 1 (reference) 1 (reference)
110–129 0.76 (0.66–0.87) 0.001 0.81 (0.70–0.95) 0.009
130–144 0.73 (0.64–0.84) 0.001 0.72 (0.61–0.85) 0.001
145 0.53 (0.44–0.63) 0.001 0.51 (0.42–0.62) 0.001
Killip class
I 1 (reference) 1 (reference)
II 1.79 (1.52–2.12) 0.001 1.70 (1.41–2.06) 0.001
III 2.37 (1.93–2.92) 0.001 2.33 (1.87–2.91) 0.001
IV 3.85 (3.19–4.64) 0.001 4.29 (3.46–5.33) 0.001
Anterior STEMI or BBBMI 1.36 (1.23–1.51) 0.001 1.36 (1.22–1.53) 0.001
Multivessel disease 1.36 (1.23–1.50) 0.001 1.40 (1.26–1.57) 0.001
NA indicates not available. Other abbreviations as in Table 1.
*Nonoverlapping intervals of treatment delay were considered for inclusion in the multivariable models: model 1, implemented treatment delay;
model 2, implemented patient delay and system delay.
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